Angiodynamics (ANGO) Income towards Parent Company (2010 - 2026)

Angiodynamics' Income towards Parent Company history runs 17 years deep, the most recent figure standing at -$11.4 million for Q2 2026.

• Quarterly Income towards Parent Company fell 88.51% year-over-year to -$11.4 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$36.7 million (down 8.09% YoY) and the FY2026 annual result came in at -$36.7 million, down 8.09% from the prior year.
• Income towards Parent Company was -$11.4 million for Q2 2026 at Angiodynamics, down from -$8.1 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $45.9 million in Q3 2023 and bottomed at -$187.7 million in Q1 2024.
• A 5-year average of -$17.7 million and a median of -$10.1 million in 2023 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2023 — Income towards Parent Company jumped 452.85% — and 2024, when it sank 1879.29%.
• Angiodynamics' Income towards Parent Company stood at -$8.5 million in 2022, then plunged by 242.3% to -$29.0 million in 2023, then soared by 63.03% to -$10.7 million in 2024, then surged by 40.86% to -$6.4 million in 2025, then slumped by 79.61% to -$11.4 million in 2026.
• Business Quant data shows ANGO's Income towards Parent Company at -$11.4 million in Q2 2026, -$8.1 million in Q1 2026, and -$6.4 million in Q4 2025.